Daudi cell Daudi 细胞 NICR425 cell NICR425 细胞 3111C0002000000053 Amelogenin:X,Y；CSF1PO:12；D13S317:11,12；D16S539:10,12；D18S51:16,18；D21S11:34,35；D3S1358:16,18；D5S818:8,13；D7S820:8,10；D8S1179:14；FGA:21,26；PentaD:10,12；PentaE:9；TH01:6,7；TPOX:8,11；vWA:15,17 Base Medium+8%DMSO+20%FBS Class A Culture Method（-） Daudi Daudi cell Daudi-cell morphology-NIFDC Human Burkitt's Lymphoma Cells; Daudi In 1967, the cell line E. Klein and G. Klein was established from a 16-year-old black man with Burkitt's lymphoma, representing beta-2-microglobulin negative, expressing EBNA, VCA, and sIg. This cell carring Epstein - Barr virus (EBV), is a typical B-lymphoblastoid cell line, which can be used to the study of Induction mechanisms for leukemia. Maintain the cell concentration between 3 � 105 to 2 ~ 3 � 106 cells/ml, and change fluid once in 2~3 days. NICR425 National Institute for Food and Drug Control RPMI 1640 (w/o Hepes) 10%FBS Shufang Meng, Xiang Zhao, Tel:67095414, 67095360, Email:mengsf@263.net Unknown http://www.cellresource.cn/fdetail.aspx?id=425 http://www.cellresource.cn/pdf/20080108101040.pdf lymphoblast-like suspension growth 1967年，该细胞系E. Klein 和 G. Klein建系，源于一名16岁患有Burkitt＇s淋巴瘤的黑人男性，beta-2-微球蛋白阴性，表达EBNA, VCA，sIg。该细胞携带EB病毒，是一个典型的B淋巴母细胞系，可用于引起白血病机制的研究。 Amelogenin:X,Y；CSF1PO:12；D13S317:11,12；D16S539:10,12；D18S51:16,18；D21S11:34,35；D3S1358:16,18；D5S818:8,13；D7S820:8,10；D8S1179:14；FGA:21,26；PentaD:10,12；PentaE:9；TH01:6,7；TPOX:8,11；vWA:15,17 A类 Daudi 细胞 Daudi-细胞形态-NIFDC RPMI 1640 (w/o Hepes) 10%FBS http://www.cellresource.cn/pdf/20080108101040.pdf 不详 中国食品药品检定研究院 人Burkitt淋巴瘤细胞；Daudi 培养法（-） 基础培养基+8%DMSO+20%FBS 孟淑芳，赵翔， Tel:67095414,67095360, Email:mengsf@263.net 悬浮生长 淋巴母细胞样 维持细胞浓度在3×105至2~3×106 cells/ml之间，2~3天换液1次。